Correction to: SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion.
Halford S., Wan S., Dragoni I., Silvester J., Nazarov B., Anthony D., Anthony S., Ladds E., Norrie J., Dhaliwal K., and the CDD SPIKE-1 Project Team None.